|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Accounts receivable—net | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property, equipment and software—net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Intangible assets—net | |||||||||||||||||||
| Deferred tax asset—noncurrent | |||||||||||||||||||
| Right-of-use assets | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Contingent consideration—current | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Deferred tax liability — noncurrent | |||||||||||||||||||
| Other liabilities—noncurrent | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||||
| Preferred stock—$0.0001 par value per share—5,000 shares authorized; zero shares issued and outstanding | |||||||||||||||||||
| Common stock—$0.0001 par value per share—296,686 shares authorized; 63,879 and 71,289 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | |||||||||||||||||||
Loading...